Home
Browse
Search
Statistics
About
Usage
PMID: 15375183
Wang J, Joy T, Mymin D, Frohlich J, Hegele RA
Phenotypic heterogeneity of sitosterolemia.
J Lipid Res. 2004 Dec;45(12):2361-7. Epub 2004 Sep 16.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
2
ABCG8 p.Ser107*
X
ABCG8 p.Ser107* 15375183:2:147
status:
NEW
view ABCG8 p.Ser107* details
We report five Canadian subjects with nonsense mutations in these half-transporters: four related Caucasian subjects were homozygous for the ABCG8
S107X
mutation, and one unrelated Japanese-Canadian subject was homozygous for a complex insertion/deletion (I/D) mutation in ABCG5 exon 3.
Login to comment
3
ABCG8 p.Ser107*
X
ABCG8 p.Ser107* 15375183:3:102
status:
NEW
view ABCG8 p.Ser107* details
ABCG8 p.Ser107*
X
ABCG8 p.Ser107* 15375183:3:147
status:
VERIFIED
view ABCG8 p.Ser107* details
We report five Canadian subjects with nonsense mutations in these half-transporters: four related Cauc
asian
subjects were homozygous for the ABCG8
S107X
mutation, and one unrelated Japanese-Canadian subject was homozygous for a complex insertion/deletion (I/D) mutation in ABCG5 exon 3.
Login to comment
4
ABCG8 p.Ser107*
X
ABCG8 p.Ser107* 15375183:4:102
status:
VERIFIED
view ABCG8 p.Ser107* details
A female subject with each mutation was symptomatic with coronary atherosclerosis: a 5-year-old ABCG8
S107X
homozygote and a 75-year-old ABCG5 exon 3 I/D homozygote; these represent the extreme ends of the spectrum of vascular involvement in sitosterolemia.
Login to comment
32
ABCG8 p.Ser107*
X
ABCG8 p.Ser107* 15375183:32:39
status:
NEW
view ABCG8 p.Ser107* details
METHODS Study subjects Family 1: ABCG8
S107X
subjects II-1 to II-4.
Login to comment
34
ABCG8 p.Ser107*
X
ABCG8 p.Ser107* 15375183:34:39
status:
VERIFIED
view ABCG8 p.Ser107* details
METHODS Study subjects Family 1: ABCG8
S107X
subjects II-1 to II-4.
Login to comment
85
ABCG8 p.Ser107*
X
ABCG8 p.Ser107* 15375183:85:59
status:
NEW
view ABCG8 p.Ser107* details
RESULTS Clinical and biochemical attributes From the ABCG8
S107X
kindred, subjects II-1 to II-4 each had high LDL-cholesterol and low HDL-cholesterol, with corresponding changes in apolipoprotein A-I (apoA-I) and apoB concentrations.
Login to comment
87
ABCG8 p.Ser107*
X
ABCG8 p.Ser107* 15375183:87:59
status:
VERIFIED
view ABCG8 p.Ser107* details
RESULTS Clinical and biochemical attributes From the ABCG8
S107X
kindred, subjects II-1 to II-4 each had high LDL-cholesterol and low HDL-cholesterol, with corresponding changes in apolipoprotein A-I (apoA-I) and apoB concentrations.
Login to comment
100
ABCG8 p.Ser107*
X
ABCG8 p.Ser107* 15375183:100:98
status:
NEW
view ABCG8 p.Ser107* details
Sequencing showed that the two younger siblings and the first cousin were also homozygous for the
S107X
mutation, whereas both parents were heterozygous.
Login to comment
101
ABCG8 p.Ser107*
X
ABCG8 p.Ser107* 15375183:101:51
status:
NEW
view ABCG8 p.Ser107* details
Additional sequence analyses showed that the ABCG8
S107X
mutation was absent from the genomic DNA of 360 healthy Caucasians.
Login to comment
102
ABCG8 p.Ser107*
X
ABCG8 p.Ser107* 15375183:102:98
status:
VERIFIED
view ABCG8 p.Ser107* details
Sequencing showed that the two younger siblings and the first cousin were also homozygous for the
S107X
mutation, whereas both parents were heterozygous.
Login to comment
103
ABCG8 p.Ser107*
X
ABCG8 p.Ser107* 15375183:103:51
status:
VERIFIED
view ABCG8 p.Ser107* details
Additional sequence analyses showed that the ABCG8
S107X
mutation was absent from the genomic DNA of 360 healthy Caucasians.
Login to comment
106
ABCG8 p.Ser107*
X
ABCG8 p.Ser107* 15375183:106:47
status:
NEW
view ABCG8 p.Ser107* details
Each of four Caucasian subjects with the ABCG8
S107X
mutation, which encodes a protein that is truncated by 80%, was ascertained under age 10 and had profound hyperlipidemia, with the index case showing marked skin manifestations and premature severe atherosclerosis with CHD.
Login to comment
108
ABCG8 p.Ser107*
X
ABCG8 p.Ser107* 15375183:108:47
status:
VERIFIED
view ABCG8 p.Ser107* details
ABCG8 p.Ser107*
X
ABCG8 p.Ser107* 15375183:108:111
status:
NEW
view ABCG8 p.Ser107* details
Each of four Caucasian subjects with the ABCG8
S107X
mutation, which encodes a protein that is truncated by ~80
%, wa
s ascertained under age 10 and had profound hyperlipidemia, with the index case showing marked skin manifestations and premature severe atherosclerosis with CHD.
Login to comment
109
ABCG8 p.Ser107*
X
ABCG8 p.Ser107* 15375183:109:23
status:
NEW
view ABCG8 p.Ser107* details
In the surviving ABGC8
S107X
homozygotes, treatment with ezetimibe or bile acid sequestrants caused the largest reductions of plasma LDL cholesterol and sitosterol, whereas treatment with statin drugs was associated with less LDL-cholesterol reduction.
Login to comment
110
ABCG8 p.Ser107*
X
ABCG8 p.Ser107* 15375183:110:111
status:
VERIFIED
view ABCG8 p.Ser107* details
One subject with each mutation was symptomatic with coronary atherosclerosis: a 5 year old girl with the ABCG8
S107X
mutation and a 75 year old woman with the ABCG5 exon 3 I/D mutation, who represent the extreme ends of the spectrum of vascular involvement in sitosterolemia.
Login to comment
111
ABCG8 p.Ser107*
X
ABCG8 p.Ser107* 15375183:111:23
status:
VERIFIED
view ABCG8 p.Ser107* details
In the surviving ABGC8
S107X
homozygotes, treatment with ezetimibe or bile acid sequestrants caused the largest reductions of plasma LDL cholesterol and sitosterol, whereas treatment with statin drugs was associated with less LDL-cholesterol reduction.
Login to comment
113
ABCG5 p.Arg389His
X
ABCG5 p.Arg389His 15375183:113:94
status:
NEW
view ABCG5 p.Arg389His details
In this ethnic group, ABCG5 exon 9 is most commonly affected, and the most common mutation is
R389H
.
Login to comment
115
ABCG5 p.Arg389His
X
ABCG5 p.Arg389His 15375183:115:94
status:
NEW
view ABCG5 p.Arg389His details
In this ethnic group, ABCG5 exon 9 is most commonly affected, and the most common mutation is
R389H
.
Login to comment
121
ABCG8 p.Ser107*
X
ABCG8 p.Ser107* 15375183:121:15
status:
NEW
view ABCG8 p.Ser107* details
Subjects ABCG8
S107X
II-1 to II-4 demonstrated a certain degree of clinical and biochemical heterogeneity (Table 2), of which the most dramatic were the cardiac and skin manifestations in subject II-1.
Login to comment
123
ABCG8 p.Ser107*
X
ABCG8 p.Ser107* 15375183:123:15
status:
VERIFIED
view ABCG8 p.Ser107* details
Subjects ABCG8
S107X
II-1 to II-4 demonstrated a certain degree of clinical and biochemical heterogeneity (Table 2), of which the most dramatic were the cardiac and skin manifestations in subject II-1.
Login to comment
125
ABCG8 p.Ser107*
X
ABCG8 p.Ser107* 15375183:125:85
status:
NEW
view ABCG8 p.Ser107* details
Interestingly, the parents of the proband, both of whom were heterozygotes for ABCG8
S107X
, had some biochemical disparities.
Login to comment
127
ABCG8 p.Ser107*
X
ABCG8 p.Ser107* 15375183:127:85
status:
VERIFIED
view ABCG8 p.Ser107* details
Interestingly, the parents of the proband, both of whom were heterozygotes for ABCG8
S107X
, had some biochemical disparities.
Login to comment